Back to Search
Start Over
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.
- Source :
- Drug Design, Development & Therapy; 2018, Vol. 12, p3985-3997, 13p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 11778881
- Volume :
- 12
- Database :
- Complementary Index
- Journal :
- Drug Design, Development & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 133503147
- Full Text :
- https://doi.org/10.2147/DDDT.S184245